tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), SAGE Therapeutics (SAGE) and Alector (ALEC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCAResearch Report), SAGE Therapeutics (SAGEResearch Report) and Alector (ALECResearch Report).

HCA Healthcare (HCA)

In a report released today, John Ransom from Raymond James maintained a Buy rating on HCA Healthcare, with a price target of $220.00. The company’s shares closed last Friday at $172.60, close to its 52-week low of $165.88.

According to TipRanks.com, Ransom is a 5-star analyst with an average return of 9.5% and a 58.2% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Encompass Health, and Tenet Healthcare.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCA Healthcare with a $235.70 average price target, which is a 35.0% upside from current levels. In a report issued on June 28, UBS also maintained a Buy rating on the stock with a $207.00 price target.

See today’s best-performing stocks on TipRanks >>

SAGE Therapeutics (SAGE)

SVB Securities analyst Marc Goodman maintained a Hold rating on SAGE Therapeutics today and set a price target of $40.00. The company’s shares closed last Friday at $36.08.

According to TipRanks.com, Goodman is a 2-star analyst with an average return of 0.2% and a 46.8% success rate. Goodman covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Opthea Limited Sponsored ADR, and Amylyx Pharmaceuticals Inc.

Currently, the analyst consensus on SAGE Therapeutics is a Moderate Buy with an average price target of $50.30.

Alector (ALEC)

Citigroup analyst Neena Bitritto-Garg maintained a Buy rating on Alector today and set a price target of $19.00. The company’s shares closed last Friday at $11.37, close to its 52-week low of $7.50.

According to TipRanks.com, Bitritto-Garg is a 2-star analyst with an average return of -1.3% and a 42.1% success rate. Bitritto-Garg covers the Healthcare sector, focusing on stocks such as Amylyx Pharmaceuticals Inc, ACADIA Pharmaceuticals, and Decibel Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alector with a $19.00 average price target, which is a 68.0% upside from current levels. In a report issued on July 8, Mizuho Securities also maintained a Buy rating on the stock with a $15.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on HCA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed